Efficacy of maggot therapy on diabetic foot ulcers

Phase 3

Recruiting

• Conditions: Diabetic foot ulcer.; Chronic ulcer of skin NOS

• Registration Number: IRCT20170723035248N2
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

Patients who have at least one diabetic foot ulcer (grade s, Wagners’ classification).
Patients who have not osteomeyelies.
Patients who have not need to be hospitalized.
Patients who have not acute or other chronic diseases.
Patients who have not need anticoagulant or steroid pharmaceutics.
Patients who have ?not addicted to alcohol or opium.

Exclusion Criteria

Patients who have sever diseases such as heart disorders and so on during maggot Therapy.
Patients who have sever pain during maggot Therapy.
Patients who get sever and un-controlled fever during maggot therapy.
Patients with maceration around the wound after each interval of maggot therapy.
Patients who need emergent hospitalization during or after of each interval of maggot therapy.
Patients who take bleeding during maggot therapy.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measuring surface of necrotic tissue. Timepoint: 48 and 96 hours after treatment. Method of measurement: photographing and measuring by MATLAB 1.6, the mathworks Inc, natic, ma, 2000.

Secondary Outcome Measures

Name	Time	Method
Bacterial infections, Staphilococcus aureus and Pseudomonas aeruginosa. Timepoint: 48 and 96 hours after treatment. Method of measurement: culturing of samples in laboratory.